Trials / Completed
CompletedNCT06396962
Survival and Prognostic Factors of Primary Retroperitoneal Sarcomas After Surgery: a Single-center Experience
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 110 (actual)
- Sponsor
- Northern Jiangsu People's Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
he percentage of retroperitoneal sarcomas (RPS) among all soft tissue sarcomas ranges from 10%-15%. Surgery remains the gold standard for RPS. In this study, we analyzed the impact of surgical treatment for primary RPS on recurrence and overall mortality at a Chinese institution and identified and evaluated prognostic variables.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | WANG DAORONG | surgery |
Timeline
- Start date
- 2024-04-29
- Primary completion
- 2024-04-29
- Completion
- 2024-04-29
- First posted
- 2024-05-02
- Last updated
- 2024-05-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06396962. Inclusion in this directory is not an endorsement.